FI950369A0 - Hedelmöitettyjä kuorellisia munia käsittävä koostumus - Google Patents

Hedelmöitettyjä kuorellisia munia käsittävä koostumus

Info

Publication number
FI950369A0
FI950369A0 FI950369A FI950369A FI950369A0 FI 950369 A0 FI950369 A0 FI 950369A0 FI 950369 A FI950369 A FI 950369A FI 950369 A FI950369 A FI 950369A FI 950369 A0 FI950369 A0 FI 950369A0
Authority
FI
Finland
Prior art keywords
pct
composition
eggs
peel
fertilized eggs
Prior art date
Application number
FI950369A
Other languages
English (en)
Swedish (sv)
Other versions
FI950369A (fi
Inventor
Bjoedne Eskeland
Peder Gjendemsjoe
Original Assignee
Drymed As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NO922988A external-priority patent/NO302335B1/no
Priority claimed from GB939314335A external-priority patent/GB9314335D0/en
Application filed by Drymed As filed Critical Drymed As
Publication of FI950369A0 publication Critical patent/FI950369A0/fi
Publication of FI950369A publication Critical patent/FI950369A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Cardiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Insulated Conductors (AREA)
  • Golf Clubs (AREA)
  • Inorganic Insulating Materials (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI950369A 1992-07-29 1995-01-27 Hedelmöitettyjä kuorellisia munia käsittävä koostumus FI950369A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO922988A NO302335B1 (no) 1992-07-29 1992-07-29 Potensfremmende middel og fremstilling derav
GB939314335A GB9314335D0 (en) 1993-07-08 1993-07-08 Composition
PCT/GB1993/001553 WO1994003192A1 (en) 1992-07-29 1993-07-22 Composition comprising fertilized shell eggs

Publications (2)

Publication Number Publication Date
FI950369A0 true FI950369A0 (fi) 1995-01-27
FI950369A FI950369A (fi) 1995-01-27

Family

ID=26303227

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950369A FI950369A (fi) 1992-07-29 1995-01-27 Hedelmöitettyjä kuorellisia munia käsittävä koostumus

Country Status (13)

Country Link
US (1) US5641517A (fi)
EP (1) EP0656781B1 (fi)
JP (1) JP3065353B2 (fi)
KR (1) KR100277095B1 (fi)
CN (1) CN1100545C (fi)
AT (1) ATE188609T1 (fi)
AU (1) AU4715093A (fi)
CA (1) CA2141197A1 (fi)
DE (1) DE69327585T2 (fi)
FI (1) FI950369A (fi)
IS (1) IS4057A (fi)
NZ (1) NZ254859A (fi)
WO (1) WO1994003192A1 (fi)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO303819B1 (no) * 1996-11-20 1998-09-07 Drymed As Anvendelse av t°rkede, fertiliserte h°nse-egg for fremstilling av anti-depressive midler
NZ527902A (en) * 2001-03-02 2005-06-24 Kalsec Inc Labiatae herb extracts and hop extracts for extending the color life and inhibiting the growth of microorganisms in fresh meat, fish and poultry
US7205151B2 (en) * 2001-06-20 2007-04-17 Metaproteomics, Llc Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
US7666449B2 (en) * 2001-06-20 2010-02-23 Metaproteomics, Llc Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
US7901713B2 (en) * 2001-06-20 2011-03-08 Metaproteomics, Llc Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops
US8168234B2 (en) * 2001-06-20 2012-05-01 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US7718198B2 (en) * 2001-06-20 2010-05-18 Metaproteomics, Llc Treatment modalities for autoimmune diseases
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
AU2008243262B2 (en) * 2001-06-20 2012-01-19 Metaproteomics, Llc Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
US7270835B2 (en) * 2001-06-20 2007-09-18 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US8142819B2 (en) * 2002-10-21 2012-03-27 Metaproteomics, Llc Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
US8206753B2 (en) * 2001-06-20 2012-06-26 Metaproteomics, Llc Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
US7901714B2 (en) * 2001-06-20 2011-03-08 Metaproteomics, Llp Treatment modalities for autoimmune diseases
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
MXPA05004288A (es) * 2002-10-21 2005-08-02 Metaproteomics Llc Composiciones para tratar o inhibir los estados patologicos asociados con la respuesta inflamatoria.
US7811610B2 (en) * 2003-05-22 2010-10-12 Metaproteomics, Llc Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
CN1332646C (zh) * 2003-10-08 2007-08-22 张洪庭 一种治疗白发脱发排毒的洗发膏
EP1722635B1 (en) 2004-02-23 2015-11-04 SSS Acquisition, LLC Feeds containing hop acids and uses thereof as supplements in animal feeds
US20050192356A1 (en) * 2004-02-27 2005-09-01 Babish John G. Synergistic anti-inflammatory pharmaceutical compositions and methods of use
US7914831B2 (en) 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
EP1817941A4 (en) * 2004-11-13 2009-11-11 Metaproteomics Llc COMPOSITIONS HAVING INHIBITION OF CYCLO-OXYGENASE-2
EP2248532A1 (en) * 2005-08-09 2010-11-10 Metaproteomics, LLP Protein kinase modulation by hops and acacia products cross-reference to related applications
WO2007067812A2 (en) * 2005-12-09 2007-06-14 Metaproteomics, Llc Protein kinase modulation by hops and acacia products
US10835576B2 (en) * 2006-05-18 2020-11-17 Myos Rens Technology Inc. Method of obtaining effective amounts of avian follistatin
US20070275036A1 (en) 2006-05-18 2007-11-29 Celldyne Biopharma, Llc Avian follistatin product
US20080026088A1 (en) * 2006-06-20 2008-01-31 Metaproteomics, Llc Reduced isoalpha acid based protein kinase modulation cancer treatment
US20080051466A1 (en) * 2006-06-20 2008-02-28 Metaproteomics, Llc Isoalpha acid based protein kinase modulation cancer treatment
JP2010505884A (ja) * 2006-10-12 2010-02-25 ユナイテッド パラゴン アソシエイツ インコーポレイテッド 受精卵の構成成分の調製方法
CA2679847A1 (en) * 2007-03-19 2008-09-25 Metaproteomics, Llc. Methods and compositions for promoting bone and joint health
US8241674B2 (en) * 2007-05-11 2012-08-14 Metaproteomics, Llc Methods and compositions for heavy metal detoxification
CA2708613A1 (en) * 2007-12-10 2009-06-18 Metaproteomics, Llc Substituted 1,3-cyclopentadione multi-target protein kinase modulators of cancer, angiogenesis and the inflammatory pathways associated therewith
AU2009203874B2 (en) 2008-01-11 2014-08-21 United Paragon Associates Inc. Fertilized egg isolate and use thereof
US20100222262A1 (en) * 2008-04-02 2010-09-02 Metaproteomics, Llc Substituted 1, 3-cyclopentadione attenuated endothelial inflammation and endothelial-monocyte interactions
GB2471827B (en) * 2009-05-11 2013-11-20 Med Eq As Treatment of stress
CN102397294A (zh) * 2010-09-07 2012-04-04 丁庆 提取自受精卵的组合物的壮阳和强精功效及其制作方法
RO128485A0 (ro) 2012-09-19 2013-06-28 Hipocrate 2002 Serv S.R.L. Compoziţie cu biodisponibilitate crescută a embrio-peptidelor administrate oral şi procedeu de obţinere
WO2015160262A1 (en) * 2014-04-16 2015-10-22 Amerikal Nutraceutical Corp Anti-aging composition
NL2023582B1 (en) * 2019-07-29 2021-02-22 Hatchtech Group Bv Use of chicken embryo meat

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1059230A (en) * 1964-12-08 1967-02-15 Arthur Samy Improvements in or relating to therapeutic products
IL63734A (en) * 1981-09-04 1985-07-31 Yeda Res & Dev Lipid fraction,its preparation and pharmaceutical compositions containing same

Also Published As

Publication number Publication date
DE69327585T2 (de) 2000-08-10
JPH08502041A (ja) 1996-03-05
ATE188609T1 (de) 2000-01-15
US5641517A (en) 1997-06-24
FI950369A (fi) 1995-01-27
CN1100545C (zh) 2003-02-05
EP0656781A1 (en) 1995-06-14
EP0656781B1 (en) 2000-01-12
WO1994003192A1 (en) 1994-02-17
KR100277095B1 (ko) 2001-11-22
CA2141197A1 (en) 1994-02-17
KR950702427A (ko) 1995-07-29
JP3065353B2 (ja) 2000-07-17
CN1098625A (zh) 1995-02-15
IS4057A (is) 1994-01-30
AU4715093A (en) 1994-03-03
NZ254859A (en) 1997-02-24
DE69327585D1 (de) 2000-02-17

Similar Documents

Publication Publication Date Title
FI950369A0 (fi) Hedelmöitettyjä kuorellisia munia käsittävä koostumus
KR950702966A (ko) 성장 호르몬의 방출을 촉진시키는 벤조 융합된 락탐(Benzo-fused lactams promote release of growth hormone)
ATE133181T1 (de) Dehydrodidemnin b
ATE433324T1 (de) Verwendung von glp-1 oder analoge zur behandlung von schlaganfall
NO942351D0 (fi)
ATE126972T1 (de) Formulierung zur behandlung von silage.
DE69332713D1 (de) Verwendung von Histamine-2 Agonisten zur Behandlung sexueller Funktionsstörungen
GR3032204T3 (en) Continuous cell line and vaccine against avian coccidia
DK0589995T3 (da) Hidtil ukendte polypeptider og deres anvendelse
DK1001775T3 (da) Medikament indeholdende yohimbin og arginin beregnet til behandling af erektil dysfunktion
MX9301789A (es) Nuevos oligopeptidos lipofilicos con actividad inmunomoduladora.
ATE179164T1 (de) Hiv-proteaseinhibitoren
DK0546007T3 (da) Produkt, og anvendelse heraf til behandling af kataboliske tilstande, omfattende autentisk IGF-1 og hypokaloriske mængder af næringsmidler
DK194990D0 (da) Aldc-derivat og anvendelse deraf
BR0016056A (pt) Formulações zootécnicas compreendendo ácidos biliares
MX9201288A (es) Metodo de tratamiento.
ZA919021B (en) Anthelmintic treatment and compositions
IL139898A0 (en) Anti-germ-attachment composition
NO960866L (no) Fremgangsmåte til behandling av leversykdom og lignende indikasjoner med vasodilaterende midler
BG103988A (en) Local aphrodisiac
周寅婕 Let Us Love the Sunshine
ATE167055T1 (de) 4-guanidinobutyramid zur verbesserung des blutkreislaufs